Molbio Diagnostics Limited
Held by 28 mutual fund schemes, ₹543.87Cr between them.
The largest single position is Kotak Aggressive Hybrid Fund (Kotak Mahindra), which holds 1.4% of its portfolio in Molbio Diagnostics Limited — ₹117.35Cr, or 21.6% of all the mutual fund money in this stock.
The five largest holders account for 54% of it, across 28 schemes in total.
13 of the 28 largest holdings sit in sectoral/ thematic funds, the most of any category here.
Funds holding Molbio Diagnostics Limited
28Largest rupee position first. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| Kotak Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.40% | ₹117.35Cr | ₹8,382Cr |
| Kotak Contra Fund | Contra Fund | 1.02% | ₹51.88Cr | ₹5,086Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 1.44% | ₹43.58Cr | ₹3,017Cr |
| Mirae Asset Flexi Cap Fund | Flexi Cap Fund | 1.02% | ₹40.86Cr | ₹4,009Cr |
| HDFC Pharma and Healthcare Fund | Sectoral/ Thematic | 1.77% | ₹40.39Cr | ₹2,282Cr |
| Nippon India Pharma Fund | Sectoral/ Thematic | 0.44% | ₹37.46Cr | ₹8,513Cr |
| HDFC Value Fund | Value Fund | 0.44% | ₹32.25Cr | ₹7,330Cr |
| Kotak Large Cap Fund | Large Cap Fund | 0.30% | ₹31.13Cr | ₹10,378Cr |
| Kotak Healthcare Fund | Sectoral/ Thematic | 4.53% | ₹24.30Cr | ₹536.45Cr |
| ICICI Prudential Quality Fund | Sectoral/ Thematic | 0.94% | ₹20.31Cr | ₹2,157Cr |
| Nippon India Innovation Fund | Sectoral/ Thematic | 0.60% | ₹16.72Cr | ₹2,787Cr |
| Kotak Consumption Fund | Sectoral/ Thematic | 0.91% | ₹15.19Cr | ₹1,669Cr |
| Motilal Oswal Large Cap | Large Cap Fund | 0.43% | ₹13.49Cr | ₹3,138Cr |
| Mirae Asset Small Cap Fund | Small Cap Fund | 0.30% | ₹12.75Cr | ₹4,246Cr |
| HDFC Innovation Fund | Sectoral/ Thematic | 0.37% | ₹9.74Cr | ₹2,632Cr |
| Edelweiss Equity Savings Fund | Equity Savings | 0.61% | ₹8.20Cr | ₹1,344Cr |
| HDFC MNC Fund | Sectoral/ Thematic | 1.51% | ₹7.93Cr | ₹525.29Cr |
| PGIM India Large and Midcap Fund | Large & Mid Cap Fund | 0.81% | ₹6.34Cr | ₹783.26Cr |
| Edelweiss Recently Listed IPO Fund | Sectoral/ Thematic | 0.59% | ₹5.80Cr | ₹983.09Cr |
| Kotak Multi Asset Allocation Fund | Multi Asset Allocation | 0.03% | ₹4.09Cr | ₹13,629Cr |
| WhiteOak Capital Multi Asset Allocation Fund | Multi Asset Allocation | 0.04% | ₹2.92Cr | ₹7,308Cr |
| PGIM India Retirement Fund | Retirement Fund | 0.94% | ₹92.00L | ₹97.87Cr |
| WhiteOak Capital Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.01% | ₹21.52L | ₹2,152Cr |
| WhiteOak Capital Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.90% | ₹3.07L | ₹3.41Cr |
| ICICI Prudential Exports & Services Fund | Sectoral/ Thematic | 1.04% | — | — |
| WhiteOak Capital Pharma and Healthcare Fund | Sectoral/ Thematic | 0.98% | — | — |
| Tata India Pharma & Healthcare Fund | Sectoral/ Thematic | 0.87% | — | — |
| Kotak Conservative Hybrid Fund | Conservative Hybrid Fund | 0.17% | — | — |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 24 of the 28 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Frequently asked questions
Which mutual fund holds the most Molbio Diagnostics Limited?
By rupee value, Kotak Aggressive Hybrid Fund from Kotak Mahindra — ₹117.35Cr, at 1.4% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Molbio Diagnostics Limited?
Kotak Healthcare Fund carries the largest weight at 4.5% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Molbio Diagnostics Limited?
28 schemes, holding ₹543.87Cr between them across the 24 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Molbio Diagnostics Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.